Bruce J Gantz1, Camille C Dunn1, Jacob Oleson2, Marlan R Hansen1. 1. Department of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City, Iowa, U.S.A. 2. Department of Biostatistics, University of Iowa, Iowa City, Iowa, U.S.A.
Abstract
OBJECTIVE: Few studies have investigated the stability of residual hearing and speech perception outcomes in individuals who were implanted with a shorter electrode device. STUDY DESIGN: Longitudinal, single-subject design. METHODS: Fifty subjects who received a Nucleus Hybrid (Cochlear, Sydney, Australia) short electrode cochlear implant (CI) and had a minimum of 2 years (and up to 15 years) of postoperative longitudinal experience were included in this study. Twenty-three subjects received a Nucleus Hybrid S8 (S8); 14 subjects received a Nucleus Hybrid L24 (L24); and 13 received a Nucleus Hybrid S12 (S12). Audiometric thresholds and consonant-nucleus-consonant (CNC) words were collected pre- and postoperatively for up to 15 years for the S8 subjects and for up to 7 years for the S12 and L24 subjects. AzBio Sentences in multi-talker babble was collected for up to 7 years on the S12 and L24 subjects. RESULTS: Longitudinally, 83% of the S8 subjects, 92% of the S12 subjects, and 86% of the L24 subjects maintained a functional hearing pure-tone average (PTA) (125-500 Hz). Predicted change using a piecewise linear mixed model in PTA over time showed a postoperative linear decrease in hearing for each group until 0.5 years, after which the PTA stabilizes and is maintained. The averaged individual data for CNC and AzBio sentences show a significant improvement in scores by 0.25 to 0.5 years postimplantation, after which scores start to reach their maximum. CONCLUSION: This long-term study demonstrates that acoustic-electric processing hearing and improvement in speech understanding in quiet and in noise can be accomplished and sustained for many years with a short electrode CI. LEVEL OF EVIDENCE: 2C. Laryngoscope, 128:473-481, 2018.
OBJECTIVE: Few studies have investigated the stability of residual hearing and speech perception outcomes in individuals who were implanted with a shorter electrode device. STUDY DESIGN: Longitudinal, single-subject design. METHODS: Fifty subjects who received a Nucleus Hybrid (Cochlear, Sydney, Australia) short electrode cochlear implant (CI) and had a minimum of 2 years (and up to 15 years) of postoperative longitudinal experience were included in this study. Twenty-three subjects received a Nucleus Hybrid S8 (S8); 14 subjects received a Nucleus Hybrid L24 (L24); and 13 received a Nucleus Hybrid S12 (S12). Audiometric thresholds and consonant-nucleus-consonant (CNC) words were collected pre- and postoperatively for up to 15 years for the S8 subjects and for up to 7 years for the S12 and L24 subjects. AzBio Sentences in multi-talker babble was collected for up to 7 years on the S12 and L24 subjects. RESULTS: Longitudinally, 83% of the S8 subjects, 92% of the S12 subjects, and 86% of the L24 subjects maintained a functional hearing pure-tone average (PTA) (125-500 Hz). Predicted change using a piecewise linear mixed model in PTA over time showed a postoperative linear decrease in hearing for each group until 0.5 years, after which the PTA stabilizes and is maintained. The averaged individual data for CNC and AzBio sentences show a significant improvement in scores by 0.25 to 0.5 years postimplantation, after which scores start to reach their maximum. CONCLUSION: This long-term study demonstrates that acoustic-electric processing hearing and improvement in speech understanding in quiet and in noise can be accomplished and sustained for many years with a short electrode CI. LEVEL OF EVIDENCE: 2C. Laryngoscope, 128:473-481, 2018.
Authors: Bruce J Gantz; Marlan R Hansen; Christopher W Turner; Jacob J Oleson; Lina A Reiss; Aaron J Parkinson Journal: Audiol Neurootol Date: 2009-04-22 Impact factor: 1.854
Authors: Alicia M Quesnel; Hideko Heidi Nakajima; John J Rosowski; Marlan R Hansen; Bruce J Gantz; Joseph B Nadol Journal: Hear Res Date: 2015-09-01 Impact factor: 3.208
Authors: Alvin deTorres; Rafal T Olszewski; Ivan A Lopez; Akira Ishiyama; Fred H Linthicum; Michael Hoa Journal: Laryngoscope Date: 2018-10-16 Impact factor: 3.325
Authors: Thomas Lenarz; Andreas Buechner; Bruce Gantz; Marlan Hansen; Viral D Tejani; Robert Labadie; Brendan O'Connell; Craig Alan Buchman; Carla V Valenzuela; Oliver F Adunka; Michael S Harris; William J Riggs; Douglas Fitzpatrick; Kanthaiah Koka Journal: Otol Neurotol Date: 2022-01-01 Impact factor: 2.311
Authors: Elizabeth L Perkins; Nauman F Manzoor; David S Haynes; Matthew O'Malley; René Gifford; Alejandro Rivas Journal: Otol Neurotol Date: 2021-07-01 Impact factor: 2.311
Authors: Viral D Tejani; Jeong-Seo Kim; Jacob J Oleson; Paul J Abbas; Carolyn J Brown; Marlan R Hansen; Bruce J Gantz Journal: J Assoc Res Otolaryngol Date: 2021-02-04
Authors: Elizabeth Perkins; Jaclyn Lee; Nauman Manzoor; Matthew O'Malley; Marc Bennett; Robert Labadie; Alejandro Rivas; David Haynes; René Gifford Journal: Otol Neurotol Date: 2021-07-01 Impact factor: 2.311